Physician profile
Jonathan B Ticker
NPI 1891724290
$11,133.73
in general payments reported to CMS, 2019-2025
7 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $962 · 2021: $4,436 · 2022: $1,974 · 2023: $328 · 2024: $2,953 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,700 · Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,700.00 |
| Food and Beverage | $876.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $4,297.50 | 2021-2022 | |
| Medical Device Business Services, INC. | $2,842.02 | 2019-2025 | |
| Depuy Synthes Sales INC. | $2,307.79 | 2021-2024 | Healix Knotless Peek, Dynacord |
| Gotham Surgical Solutions & Devices, INC. | $962.00 | 2020 | |
| Stryker Corporation | $357.42 | 2019-2023 | Crossflow |
| Linvatec Corporation | $201.26 | 2023-2025 | Biobrace 23mm, Allograft Tissue, Linvatec Shoulder Arthroscopy |
| Exactech, INC. | $165.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ticker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.